Exact Mass: 491.15148400000004

Exact Mass Matches: 491.15148400000004

Found 36 metabolites which its exact mass value is equals to given mass value 491.15148400000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Capensinin

3,7,4-Trihydroxy-5,3,5-trimethoxyflavylium 3-rhamnoside

C24H27O11 (491.1553292)

Asp Asp Asp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-carboxypropanamido]-4-carbamoylbutanoic acid

C17H25N5O12 (491.149965)

Asp Asp Glu Asn

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C17H25N5O12 (491.149965)

Asp Asp Asn Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]pentanedioic acid

C17H25N5O12 (491.149965)

Asp Asp Gln Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-4-carbamoylbutanamido]butanedioic acid

C17H25N5O12 (491.149965)

Asp Glu Asp Asn

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}butanoic acid

C17H25N5O12 (491.149965)

Asp Glu Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]-3-carbamoylpropanamido]butanedioic acid

C17H25N5O12 (491.149965)

Asp Asn Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]pentanedioic acid

C17H25N5O12 (491.149965)

Asp Asn Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-4-carboxybutanamido]butanedioic acid

C17H25N5O12 (491.149965)

Asp Gln Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-3-carboxypropanamido]butanedioic acid

C17H25N5O12 (491.149965)

Glu Asp Asp Asn

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}butanoic acid

C17H25N5O12 (491.149965)

Glu Asp Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]butanedioic acid

C17H25N5O12 (491.149965)

Glu Asn Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]butanedioic acid

C17H25N5O12 (491.149965)

Asn Asp Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-carboxypropanamido]pentanedioic acid

C17H25N5O12 (491.149965)

Asn Asp Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-4-carboxybutanamido]butanedioic acid

C17H25N5O12 (491.149965)

Asn Glu Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carboxybutanamido]-3-carboxypropanamido]butanedioic acid

C17H25N5O12 (491.149965)

Gln Asp Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]-3-carboxypropanamido]butanedioic acid

C17H25N5O12 (491.149965)

4-[[5-(acetylamino)-1H-indol-3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]-Benzamide

C26H25N3O5S (491.15148400000004)

(((((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)Methyl)phosphoryl)bis(oxy))bis(Methylene) isopropyl Methyl dicarbonate

C17H26N5O10P (491.14172260000004)

N-(1-dibutoxyphosphoryl-4-oxo-1-naphthalenyl)benzenesulfonamide

C24H30NO6PS (491.1531370000001)

3-Amino-2-[(4-methoxyanilino)-oxomethyl]-4-(4-methoxyphenyl)-6-methyl-5-thieno[2,3-b]pyridinecarboxylic acid ethyl ester

C26H25N3O5S (491.15148400000004)

6-amino-5-cyano-2-[[(3-cyano-6-methyl-7,8-dihydro-5H-1,6-naphthyridin-2-yl)thio]methyl]-4-(4-fluorophenyl)-4H-pyran-3-carboxylic acid methyl ester

C25H22FN5O3S (491.1427314)

2-[[2-(Cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-[1-oxo-2-[[oxo(thiophen-2-yl)methyl]amino]ethyl]amino]acetic acid ethyl ester

C23H29N3O5S2 (491.15485440000003)

IGUANA-1

C27H26ClN3O4 (491.1611746000001)

IGUANA-1 is a potent inhibitor of ALDH1B1, which is a mitochondrial enzyme that promotes colorectal and pancreatic cancer. IGUANA-1 has significant inhibition against cancer cells[1].

(s)-{[(2s,3s,4s)-2-amino-1,3,4-trihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-5-methyl-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid

C17H25N5O12 (491.149965)

n-[(2r,3s,4r,6r)-3-hydroxy-2-methyl-6-(1,6,8-trihydroxy-3-methyl-7,12-dioxotetraphen-5-yl)oxan-4-yl]ethanimidic acid

C27H25NO8 (491.158009)

{[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}[(2r,3s,4r,5r)-3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl]acetic acid

C17H25N5O12 (491.149965)

(4s)-2-(6-chloro-4-hydroxy-1-methylindol-3-yl)-n-[(1s)-2-hydroxy-2-[(methoxycarbonyl)imino]-1-[(2r)-pyrrolidin-2-yl]ethyl]-4-methyl-5h-1,3-oxazole-4-carboximidic acid

C22H26ClN5O6 (491.1571526000001)

n-[3-hydroxy-2-methyl-6-(1,6,8-trihydroxy-3-methyl-7,12-dioxotetraphen-5-yl)oxan-4-yl]ethanimidic acid

C27H25NO8 (491.158009)

(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1-sulfanyl-n-[(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]methanimidate

C20H29NO11S (491.1461244000001)

2-(6-chloro-4-hydroxy-1-methylindol-3-yl)-n-{2-hydroxy-2-[(methoxycarbonyl)imino]-1-(pyrrolidin-2-yl)ethyl}-4-methyl-5h-1,3-oxazole-4-carboximidic acid

C22H26ClN5O6 (491.1571526000001)

{[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}({3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl})acetic acid

C17H25N5O12 (491.149965)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1-sulfanyl-n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)methanimidate

C20H29NO11S (491.1461244000001)